MedPath

Comparison of the Accuracy and Precision of a Zero Heat Flux Thermometer (SpotOn) Versus Pulmonary Artery Temperature.

Completed
Conditions
Cardiac Surgical Procedures
Temperature Monitoring
Interventions
Device: Zero Heat Flux Thermometer
Registration Number
NCT05737147
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

In this study, we aim to compare the core temperature measured with two noninvasive ZHF thermometers and a urinary bladder thermometer against a gold standard blood temperature measured in the pulmonary artery in patients undergoing on-pump cardiac surgery. Additionally we intend to compare the reproducibility of the ZHF measurements by using two devices simultaneously in each patient.

Detailed Description

Anesthesia will be induced with fentanyl, propofol and rocuronium and maintained with sevoflurane and fentanyl or sevoflurane and remifentanil infusion. Hypotension after induction of anesthesia will be treated primarily with phenylephrine or ephedrine and secondarily with norepinephrine infusion.

After induction of anesthesia a PAC (Edwards Lifescience, Thermodilution Paceport Catheter 931F75, 7.5F (2.5 mm) 110 cm) will be inserted in the pulmonary artery and connected to a Vigilance 2-monitor. Core temperature at the tip of the PAC will be measured every minute and displayed on the monitor. Two SpotOn™ ZHF temperature monitoring probes (3M, Model 370 Temperature Monitoring System, St. Paul, MN) will be fixed on the skin of the left and right side of the forehead above the eyebrow before induction of anesthesia. These devices also measured core temperature every minute and displayed the values on two display screens. In addition a temperature-sensing indwelling urinary catheter (CovidienTM, Mon-a-ThermTM, Foly Catheter with temperature sensor 400TM) will be placed after induction of anesthesia to allow continuous drainage of urine and continuous measurement of body temperature.

Core temperatures measured by PAC, ZHF-thermometer and bladder thermometer will be recorded with an interval of 1 minute.

In all patients the core temperature are allowed to drop until going on CPB. There will be no no external warming or infusion warming before CPB. At initiation of CPB measurements will stop because during CPB core temperatures measured with PAC does not produce an accurate estimate of core temperature.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adult patients of both genders scheduled for cardiac surgery with CPB for either coronary artery bypass grafting (CABG), aortic valve replacement (AVR), mitral valve replacement (MVR) or CABG + AVR
Exclusion Criteria
  • Exclusion criteria if any interruption of skin on the forehead, planned direct heat application to the forehead, or previous cerebral stroke, that might affect the accuracy of the ZHF device

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
100 adult patients of both genders scheduled for cardiac surgeryZero Heat Flux Thermometer100 adult patients of both genders scheduled for cardiac surgery with CPB for either coronary artery bypass grafting (CABG), aortic valve replacement (AVR), mitral valve replacement (MVR) or CABG + AVR.
Primary Outcome Measures
NameTimeMethod
ZHF temperature right side versus ZHF temperature left sidePerioperatively

ZHF temperature measured on the right side of the forehead versus ZHF temperature measured on the left side of the forehead

ZHF temperature right side versus PAC temperature.Perioperatively

ZHF temperature measured on the right side of the forehead versus PAC temperature.

ZHF temperature left side versus PAC temperature.Perioperatively

ZHF temperature measured on the left side of the forehead versus PAC temperature.

Bladder temperature versus PAC temperaturePerioperatively

Bladder temperature versus PAC temperature

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rigshospitalet, Copenhagen University Denmark

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath